These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1693662)

  • 1. Neutralization epitopes of human rhinovirus type 2.
    Appleyard G; Russell SM; Clarke BE; Speller SA; Trowbridge M; Vadolas J
    J Gen Virol; 1990 Jun; 71 ( Pt 6)():1275-82. PubMed ID: 1693662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14.
    Sherry B; Mosser AG; Colonno RJ; Rueckert RR
    J Virol; 1986 Jan; 57(1):246-57. PubMed ID: 2416951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nature and spatial distribution of amino acid substitutions conferring resistance to neutralizing monoclonal antibodies in human rhinovirus type 2.
    Speller SA; Sangar DV; Clarke BE; Rowlands DJ
    J Gen Virol; 1993 Feb; 74 ( Pt 2)():193-200. PubMed ID: 8381460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a new neutralization epitope on VP7 of human serotype 2 rotavirus and evidence for electropherotype differences caused by single nucleotide substitutions.
    Dunn SJ; Ward RL; McNeal MM; Cross TL; Greenberg HB
    Virology; 1993 Nov; 197(1):397-404. PubMed ID: 7692670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing antibodies to human rhinovirus produced in laboratory animals and humans that recognize a linear sequence from VP2.
    Hastings GZ; Speller SA; Francis MJ
    J Gen Virol; 1990 Dec; 71 ( Pt 12)():3055-9. PubMed ID: 1703215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for at least two dominant neutralization antigens on human rhinovirus 14.
    Sherry B; Rueckert R
    J Virol; 1985 Jan; 53(1):137-43. PubMed ID: 2981332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the location of antigenic sites of swine vesicular disease virus with neutralization-resistant mutants.
    Kanno T; Inoue T; Wang Y; Sarai A; Yamaguchi S
    J Gen Virol; 1995 Dec; 76 ( Pt 12)():3099-106. PubMed ID: 8847515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and characterization of a poliovirus/rhinovirus antigenic hybrid.
    Altmeyer R; Murdin AD; Harber JJ; Wimmer E
    Virology; 1991 Oct; 184(2):636-44. PubMed ID: 1653493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the neutralizing epitopes on the glycoprotein of infectious haematopoietic necrosis virus, a fish rhabdovirus.
    Huang C; Chien MS; Landolt M; Batts W; Winton J
    J Gen Virol; 1996 Dec; 77 ( Pt 12)():3033-40. PubMed ID: 9000094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the neutralization epitopes on human rotavirus VP7 recognized by monotype-specific monoclonal antibodies.
    Kobayashi N; Taniguchi K; Urasawa T; Urasawa S
    J Gen Virol; 1991 Aug; 72 ( Pt 8)():1855-61. PubMed ID: 1714939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of neutralization-escape mutants selected from a mouse virulent type 1/type 2 chimeric poliovirus: identification of a type 1 poliovirus with antigenic site 1 deleted.
    Couderc T; Martin A; Wychowski C; Girard M; Horaud F; Crainic R
    J Gen Virol; 1991 Apr; 72 ( Pt 4)():973-7. PubMed ID: 1707949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular relationships between 21 human rhinovirus serotypes.
    Horsnell C; Gama RE; Hughes PJ; Stanway G
    J Gen Virol; 1995 Oct; 76 ( Pt 10)():2549-55. PubMed ID: 7595358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A neutralizing epitope on human rhinovirus type 2 includes amino acid residues between 153 and 164 of virus capsid protein VP2.
    Skern T; Neubauer C; Frasel L; Gründler P; Sommergruber W; Zorn M; Kuechler E; Blaas D
    J Gen Virol; 1987 Feb; 68 ( Pt 2)():315-23. PubMed ID: 2434607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of monoclonal antibodies for the identification of the antigenic site for poliovirus neutralization.
    Minor PD; Schild GC; Evans D; Ferguson M; Almond J
    Dev Biol Stand; 1984; 57():171-5. PubMed ID: 6084608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for at least four antigenic sites on type O foot-and-mouth disease virus involved in neutralization; identification by single and multiple site monoclonal antibody-resistant mutants.
    McCahon D; Crowther JR; Belsham GJ; Kitson JD; Duchesne M; Have P; Meloen RH; Morgan DO; De Simone F
    J Gen Virol; 1989 Mar; 70 ( Pt 3)():639-45. PubMed ID: 2471793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus.
    Arbiza J; Taylor G; López JA; Furze J; Wyld S; Whyte P; Stott EJ; Wertz G; Sullender W; Trudel M
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2225-34. PubMed ID: 1383404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revertants of poliovirus escape mutants: new insights into antigenic structures.
    Ketterlinus R; Wiegers K; Dernick R
    Virology; 1993 Feb; 192(2):525-33. PubMed ID: 8380664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of monoclonal antibodies raised against a synthetic peptide capable of inducing a neutralizing response to human rhinovirus type 2.
    Barnett PV; Rowlands DJ; Parry NR
    J Gen Virol; 1993 Jul; 74 ( Pt 7)():1295-302. PubMed ID: 8393073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Mengo virus neutralization epitopes. II. Infection of mice with an attenuated virus.
    Kobasa D; Mulvey M; Lee JS; Scraba DG
    Virology; 1995 Dec; 214(1):118-27. PubMed ID: 8525606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing epitopes of type O foot-and-mouth disease virus. I. Identification and characterization of three functionally independent, conformational sites.
    Barnett PV; Ouldridge EJ; Rowlands DJ; Brown F; Parry NR
    J Gen Virol; 1989 Jun; 70 ( Pt 6)():1483-91. PubMed ID: 2471811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.